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Peripheral nociceptors are excited by the activation of membrane receptors and ion channels. The heat-sensitive TRPV1 ion channel
responds to various noxious chemical and thermal stimuli, causing pain and itch. Here, we show that TRPV1 is coexpressedwith PKCII
in a subset of mouse sensory neurons and that, in these neurons, TRPV1 binds directly to PKCII, leading to the activation and translo-
cation of PKCII. Activated PKCII, in turn, significantly increases the responsiveness of TRPV1 by phosphorylating Thr705. The heat
sensitivity of TRPV1 is almost eliminated by either knocking downPKCII ormutating Thr705; however, neither of thesemanipulations
affects the potentiation of TRPV1 caused by the activation of PKC. PKCII thus acts as an auxiliary subunit of TRPV1 by forming a
population-dependent TRPV1 ion channel complex controlling the sensitivity of TRPV1 and setting the threshold for pain and itch.
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Introduction
The responsiveness of animals to noxious stimuli depends on the
sensitivity of nociceptors in peripheral nerve endings. Many ion
channels in nociceptive neurons serve as sensors or transducers
conveying noxious information to the CNS. TRPV1 is such an
ion channel that responds to diverse pain-producing agents, in-
flammatory mediators, and metabolites such as bradykinin and
protons (Basbaum et al., 2009). TRPV1 is also targeted directly by
toxins derived from tarantula spider venom, producing pain and
inflammation (Siemens et al., 2006). Interestingly, excitation of
TRPV1 by histamine in a subpopulation of dorsal root ganglion
(DRG) neurons mediates the sensation of itch instead of pain
(Shim et al., 2007). In addition to being targeted by these painful
and itching chemicals, TRPV1 is best known for its direct activa-
tion by noxious heat (Caterina et al., 1997). The basal sensitivity
of TRPV1 in response to these noxious stimuli is thus critical for
the latency and intensity of elicited pain and itch; however, it is
little known about how the basal sensitivity of TRPV1, and in
particular its thermal sensitivity, is determined.
It is well known that different populations of TRPV1 neu-
rons exhibit differential sensitivities to heat even though they
respond similarly to the agonist capsaicin; conversely, not all
capsaicin-responding neurons are heat sensitive (Kirschstein et
al., 1997; Vyklicky´ et al., 1999). Furthermore, there are many
discrepancies between heat- and capsaicin-evoked currents in
DRGneurons, leading to speculation that different TRPV1 chan-
nel complexes may have been formed in different populations of
neurons (Nagy andRang, 1999b); however, no suchTRPV1 com-
plexes have ever been identified. Membrane lipids are negative
regulators of the basal sensitivity of TRPV1 (Cao et al., 2013), but
it is unknown whether different populations of neurons have
different levels of phosphoinositide lipids giving rise to different
sensitivities of TRPV1. Collectively, themechanisms causing var-
ied thermal sensitivity of TRPV1 are still poorly understood.
In contrast, the mechanisms underlying the modulation of
TRPV1 sensitivity in disease conditions such as inflammation are
relatively well understood. During inflammation, the thermal
threshold of TRPV1 is reduced significantly, leading to inflam-
matory thermal hyperalgesia through a mechanism involving
sensitization of TRPV1 via phosphorylation of the channel by
activated PKA or PKC (Huang et al., 2006). Sensitization of
TRPV1 also requires the scaffolding protein AKAP79/150, which
anchors both PKA andPKCadjacent to TRPV1 (Jeske et al., 2008;
Schnizler et al., 2008; Zhang et al., 2008; Jeske et al., 2009). How-
ever, it is unknown whether this mechanismmay also determine
the basal sensitivity of TRPV1.
Here, we report that the basal sensitivity of TRPV1 is deter-
mined mainly by PKCII, but not by PKC. TRPV1 is sufficient
to activate PKCII through direct binding to the kinase domain
of PKCII. Activated PKCII then phosphorylates TRPV1 at the
residue Thr705, leading to an increased sensitivity of TRPV1.
Coexpression of PKCII and TRPV1 was found in a subpopula-
tion of DRG neurons, where they form a population-dependent
TRPV1 ion channel complex. This population of TRPV1
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neurons may represent a subset of hypersensitive nociceptive
neurons.
Materials andMethods
Cell culture and transfection
HEK293 cells andHEK293Tet-on advanced cells (Clontech)weremain-
tained in DMEM containing 10% FBS, 100 UI/ml ampicillin, 100 g/ml
streptomycin, and 2 mM L-glutamine in a humidified incubator contain-
ing 5% CO2. For the culture of HEK 293 Tet-on cells, 500 g/ml G-418
(Sigma) was also included in themedium. Cells were transfected with the
polyfect transfection reagent (QIAGEN), as described previously (Zhang
et al., 2012), and used for electrophysiology 2 d after transfection. For
Western blotting, cells were transfected with TurboFect reagent (Fer-
mentas) according to the manufacturer’s instructions.
DRG neurons were isolated from neonatal Wistar rats (7 d), wild-
type C57BL/6 mice, and TRPV1-null mice of either sex, and cultured as
described previously (Zhang et al., 2008). Briefly, DRG were collected
and dissociated with collagenase IV (Worthington). Dissociated neurons
were then cultured in the DMEM containing 50 ng/ml NGF (Promega)
and 1.2g/ml cytosine-D-arabinofuranoside. in some experiments, neu-
rons were transfected with the Amaxa rat neuron nucleofector kit using a
nucleofection device according to the manufacturer’s instructions.
cDNA constructs
GFP-PKCII was kindly provided by Dr. Yusuf Hannun (Feng et al.,
1998). PKCII was a kind gift fromDr. AlexandraNewton (University of
California at San Diego). To induce PKCII expression in the Tet-On
expression system, the coding cDNA for PKCII or its kinase domain
was incorporated into the pTRE2 vector (Clontech) through BamHI and
XbaI. The GST-coupled TRPV1 N-terminal and C-terminal fragments
were constructed and used as described previously (Zhang et al., 2005).
The GST-coupled C1C2 domain and the kinase domain from PKCII
were constructed by incorporating PKCII fragments into the GST-
pcNDA3 mammalian expression vector. The human PKCII shRNA
was constructed by ligating synthesized oligos (targeting sequence: 5-
GGTCATGCTTTCAGAACGAAA-3) into the siRNA expression vector
pGSU6-GFP (Genlantis) though BamHI andNotI according to theman-
ufacturer’s instructions. The corresponding scrambled sequence was 5-
ATAGGATACGGACGTCATATC-3. The targeting sequence for rat
PKCII was 5-GGTACCAAGGCTCCAGAAGAA-3. The human PKC
shRNA was constructed similarly by targeting the following sequence:
5-GGTCATGTTGGCAGAACTCAA-3. The corresponding scrambled
sequence was 5-ATAGCCAGAACGGTTGTCTAG-3. Successfully
transfected cells were identified using the coexpressed gene reporter GFP
from the shRNA vector. All other mutations were generated using the
Site-DirectedMutagenesis Kit (Agilent) according to themanufacturer’s
instructions. All constructs were confirmed by DNA sequencing.
Protein biochemistry
GST pull down. The GST-coupled TRPV1 N-terminal and C-terminal
fragments were expressed and purified from BL21 cells, as described
previously (Zhang et al., 2008). Purified protein fragments were then
incubated with pure PKCII (Merck). For pull down of TRPV1 by
PKCII fragments, HEK293 cells expressing GST-coupled PKCII pro-
tein fragments andTRPV1were solubilized in a lysis buffer containing 10
mM Tris, 1.0% NP-40, 150 mM NaCl, 1.0 mM EDTA, and 1.0 mM EGTA
plus protease inhibitor mixture (Roche). GST-binding proteins were
then pulled down by glutathione-agarose (Sigma), followed by extensive
washing. Proteins interacting with GST-coupled protein fragments were
analyzed on a 10% SDS-PAGE gel.
Immunoprecipitation. Coimmunoprecipitation was performed as de-
scribed previously (Zhang et al., 2008). TRPV1 from DRG lysates was
precipitated by anti-TRPV1 antibody (Santa Cruz Biotechnology) and
then isolated by protein A-agarose. To investigate the interactions be-
tween TRPVs (TRPV1, TRPV2, TRPV3, and TRPV4) and PKCII, HEK
293 cells transfectedwith cDNAs coding for TRPVs-V5 andPKCII were
solubilized in the lysis buffer, followed by incubation with anti-V5 anti-
body (Invitrogen) and protein A-agarose (Santa Cruz Biotechnology).
Agarose-associated proteins were then dissociated with a sample buffer
and analyzed on SDS-PAGE gels.
In vitro PKC phosphorylation assay. Phosphorylation of the purified
GST-coupled TRPV1 C-terminal fusion protein by PKCII was con-
ducted in a 30l of kinase buffer containing 25mMTris-HCl, pH 7.5, 0.5
mMDTT, 10mMMgCl2, 0.6mMCaCl2, 100MATP, and 1g of purified
GST-C-TRPV1orGST-C-T705ATRPV1protein fragments plus 25 ng of
PKCII (Enzo Life Sciences). To determine whether TRPV1 enhances
PKCII activity, PKCII was also precipitated by the anti-GFP antibody
(Santa Cruz Biotechnology) from HEK293 cell lysate containing GFP-
PKCII either alone or together with TRPV1 (see Fig. 4H ). Immunopre-
cipitated PKCII was washed three times with the lysis buffer and twice
with the kinase buffer and then incubated with 30 l of kinase buffer in
the presence of 1g ofGST-C-TRPV1 fusion protein. The reactionswere
incubated at 30°C for 60min and terminated by boiling in sample buffer,
followed by analysis on SDS-PAGE gels. Phosphorylation of fusion pro-
teins was detected using the anti-phosphothreonine antibody (Cell Sig-
naling Technology).
Western blotting. Protein samples were resolved on 10% SDS-PAGE
gels and then transferred to a PVDF membrane. Blots were incubated
with primary antibodies, followed by horseradish peroxidase-conjugated
secondary antibodies (GE healthcare). Proteins on the blot were visualized
by enhanced chemiluminescence (Pierce). The PKCII and PKC antibod-
ies were obtained from Santa Cruz Biotechnology, the tubulin antibodywas
from Sigma, and the GST antibody was fromGEHealthcare.
Immunocytochemistry
Cultured DRG neurons were fixed with 4% paraformaldehyde and then
permeabilized with 0.1%Triton X-100. After blocking with 0.1% gelatin,
cells were incubated with mouse anti-TRPV1 (Santa Cruz Biotechnol-
ogy) and rabbit anti-PKCII antibodies, followed by secondary antibod-
ies (Alexa Fluor 594 anti-mouse and Alexa Fluor 488 anti-rabbit; both
from Life Technologies). Cells were mounted onto a slide for examina-
tion by confocal microscopy. The localization of PKCII was examined
visually by two independent experimenters. A distinct, ring-like staining of
PKCII (see Fig. 1B) was considered to indicate localization at the plasma
membrane; otherwise, localization was considered to be cytoplasmic.
Electrophysiology
Whole-cell patch clamping was performed as described previously
(Zhang et al., 2008; Zhang et al., 2012). Electrodes were fabricated from
glass capillaries using a micropipette puller (Sutter Instruments). The
electrodes had resistances of 2–4 M when filled with internal solution
containing the following (in mM): 140 KCl, 2.0 MgCl2, 5.0 EGTA, 10
HEPES, pH 7.4, with KOH. Cells were perfused with a bath solution
containing the following (in mM): 140 KCl, 1.0 MgCl2, 1.8 CaCl2, 10
HEPES, pH 7.4, with KOH. TRPV1 inward currents were measured at a
holding potential of 60 mV. To determine temperature-induced acti-
vation of TRPV1, the temperature of the perfusion solution was con-
trolled by a Peltier device (CV Scientific), generating a ramp of
temperatures from 21° up to 48°C. The I–V relationship of TRPV1 chan-
nels was revealed using a rampprotocol starting at120mV, followed by
a 650 ms linear ramp-up to 160 mV. To examine TRPV1 activation by
depolarization, 0 mV of initial holding potential was applied followed
by steps of 100ms voltage pulses ranging from140mV to200mV in
20 mV increments, with a final step to60 mV. The half-maximal acti-
vation voltage (V1/2) was obtained by the fitting normalized channel
conductance (G/Gmax)-voltage relationship to a Boltzmann equation as
follows: G/Gmax  G0/Gmax  1/(1  exp[(Vm  V1/2)/k]). Series
resistance was routinely 10.0 M and was compensated 75%. For
neuronal recordings, we chose small rat DRG neurons (25 M). All
recordings were made at room temperature (24°C) unless otherwise
stated with an Axopatch 200B patch clamp amplifier (Axon) associated
with pClampex version 10.2 software (Molecular Devices). Signals were
analog filtered using a 1 kHz low-pass Bessel filter.
Statistics
All data are presented as mean	 SEM. Differences between groups were
evaluated by one-way ANOVA with Bonferroni’s post hoc test unless
otherwise stated. Results were considered significant at p 0.05.
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Results
TRPV1 causes the translocation of PKCII in a subset of
DRG neurons
PKC comprises a family of important signaling kinases involved
in many biological processes. It is mainly located in the cyto-
plasm. The translocation of PKC to the cell membrane is a hall-
mark of PKC activation and is elicited by a concerted cascade of
second signaling messengers such as diacylglycerol and calcium
(Parker andMurray-Rust, 2004). We investigated the expression
of PKCII and PKC in DRG neurons. Consistent with a previ-
ous report (Cesare et al., 1999), PKC was mainly expressed in
the cytoplasm in all DRG neurons (Fig. 1A). Similar observations
were also made for PKCII in a proportion of DRG neurons
(38%; Fig. 1B). However, PKCII was expressed on the plasma
membrane in a subpopulation of small DRG neurons (17%; Fig.
1B–E). Interestingly, this latter subpopulation of DRG neurons
always coexpressed TRPV1 (Fig. 1B,D). In contrast, TRPV1 was
not expressed inmost of the neurons (87%) inwhich PKCII was
localized in the cytoplasm (Fig. 1B,D). The membrane localiza-
tion of PKCII is thus highly correlated with coexpression of
TRPV1 in DRG neurons.
To investigate whether TRPV1 drives the translocation of
PKCII to the cell membrane, we performed colocalization stud-
ies in neurons isolated from mice lacking the TRPV1 gene. As
anticipated, the membrane expression of PKCII was almost ab-
sent fromDRGneurons deficient in TRPV1 (Fig. 1F), supporting
the idea that TRPV1 does indeed cause the translocation of
PKCII in a subset of DRG neurons.
TRPV1 binds directly to PKCII
The close relationship between coexpression of TRPV1 and
translocation of PKCII can also be recapitulated in an in vitro
expression system. Figure 2A shows that PKCII was expressed in
the cytoplasm of HEK293 cells in the absence of TRPV1, but was
translocated to the membrane in cells coexpressing TRPV1.
These data suggest that PKCII may bind directly to TRPV1,
leading to the translocation of PKCII. Indeed, PKCII can be
coprecipitated by TRPV1 from both DRG neurons and HEK293
cells expressing both proteins (Fig. 2B,C). Binding of PKCII to
TRPV1 is twice as strong as both control and binding to other
members of TRPV family (TRPV2, TRPV3, andTRPV4; Fig. 2C).
To determine whether the interaction between TRPV1 and
PKCII is direct or indirect, we used the GST-coupled cytoplas-
mic fragments of TRPV1 to pull down purified PKCII. Figure
2D shows that PKCII binds only to the TRPV1 N terminus, not
to a control GST tag or to the TRPV1 C terminus. In contrast,
neither the N terminus nor the C terminus of TRPV1 bound
directly to PKC in a similar experiment (Fig. 2E). The lack of
direct binding of PKC to TRPV1 is consistent with the finding
that PKC requires the scaffolding protein AKAP79/150 to me-
diate an indirect interaction with TRPV1 (Zhang et al., 2008).
These data demonstrate that TRPV1 binds directly to PKCII,
but not to PKC, leading to the translocation of PKCII.
We then investigated further which regions on PKCII are
responsible for its binding to TRPV1. PKCII contains two im-
portant structural domains, the C1C2 domain and the catalytic
kinase domain. Both domains are essential for the activation of
PKCII. We constructed protein fragments for these two do-
mains and coupled them to a GST tag for a GST pull-down assay.
TRPV1 was pulled down by the kinase domain, but not by the
C1C2 domain of PKCII nor by a control GST tag (Fig. 2F).
Binding to the kinase domain of PKCII is specific to TRPV1
because none of other TRPVs (TRPV2, TRPV3, or TRPV4) was
pulled down by the same domain of PKCII (Fig. 2G), which is
consistent with the results of the coimmunoprecipitation exper-
iment (Fig. 2C). These experiments demonstrate that TRPV1
binds directly to the kinase domain of PKCII, an event that may
Figure 1. TRPV1 causes the translocation of PKCII in DRG neurons. A, Example of double immunostaining of PKC and TRPV1 in DRG neurons. PKCwas expressed in the cytoplasm in all DRG
neurons regardless ofwhether TRPV1was coexpressed. Scale bars, 10m.B, Sample images of immunolocalization of TRPV1 (middle) andPKCII (left) in DRGneurons. On the right are bright-field
images of neurons. Scale bars, 10m. C, Distribution of TRPV1- and PKCII-expressing DRG neurons. n 470 cells.D, Summary of percentages of neuronswithmembrane and cytosol localization
in neurons expressing only TRPV1 (n 178 cells) and neurons expressing both TRPV1 and PKCII (n 80 cells). E, F, Histogram distribution of membrane and cytoplasm-localized PKCII as a
function of cell diameter in neurons isolated fromwild-type (WT) mice (E; n 321 cells) and from TRPV1-null mice (F; n 502 cells).
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expose the kinase domain, leading to the translocation and thus
activation of PKCII.
PKCII causes the downregulation of TRPV1 by
phosphorylating the channel
We further examined the expression of TRPV1 and PKCII in
HEK293 cells coexpressing the two proteins. Surprisingly, coex-
pression of PKCII caused the downregulation of TRPV1 (Fig.
3A). Similar TRPV1 downregulation was also observed with
PKC, another member of the conventional PKC family. How-
ever, other members of PKC family, such as PKC or PKC, had
no effect onTRPV1 expression (Fig. 3A). Reciprocally, the down-
regulation of TRPV1was accompanied by the reduced expression
of PKC and PKCII (Fig. 3A,B), but no expression changes in
PKC or PKC were observed upon coexpression with TRPV1
(Fig. 3A,B).
To monitor the downregulation of TRPV1 by PKCII dy-
namically, we incorporated PKCII into a pTRE2 vector contain-
ing a Tet-On promoter, the activity of which can be controlled by
doxycycline (DOX). Under this Tet-On system, the expression of
PKCII can be induced dynamically by DOX. We then coex-
pressed TRPV1 with PKCII-pTRE2 in Tet-On HEK293 cells.
Fig. 3C shows that the expression of PKCII is gradually in-
creased after the addition of DOX and, correspondingly, the ex-
pression of TRPV1 begins to fall after 8 h. The downregulation of
TRPV1 becomes prominent after 24 h ofDOX induction. In all of
following functional studies, we used 8 h of PKCII induction to
avoid excessive downregulation of TRPV1 protein.
We next examined the mechanisms causing the downregula-
tion of TRPV1 by PKCII. The downregulation of TRPV1 is not
caused by the actions of knownproteases such as caspase, calpain,
and metalloprotease (Fig. 3D) nor by a nonspecific interference
with TRPV1 transcription due to PKCII coexpression (data not
shown). It is also not a result of proteolysis in proteasomes or
lysosomes, two principal proteolytic systems in cells, because in-
hibitors for these enzymes and organelles did not prevent the
downregulation of TRPV1 caused by PKCII (Fig. 3D,E, and
data not shown). The downregulation of TRPV1 and PKCII
was, however, prevented by either the general TRP channel pore
blocker ruthenium red (RR) or, even more potently, by the spe-
cificTRPV1blockerN-(4-tertiarybutylphenyl)-4-(3-chloropyridin-
2-yl)tetrahydropyrazine-1(2H)-carbox-amide (BCTC; Fig. 3F,G),
Figure 2. TRPV1 binds directly to PKCII. A, Localization of PKCII (left) and TRPV1 (middle) in HEK 293 cells expressing GFP-PKCII and TRPV1. On the right is a merged image. Scale bars, 10
m.B, PKCII was coprecipitated by TRPV1 in DRG neurons. TRPV1was precipitated by anti-TRPV1 or a control IgG followed by the detectionwith anti-PKCII (top blot). The blotwas stripped and
reprobed with anti-TRPV1 antibody (bottom blot). Molecular weight is shown on the right and is the same in all other blots. C, TRPV proteins were precipitated by anti-V5 from HEK293 cell lysates
expressing PKCII together with different TRPV channels (all tagged with V5) as indicated, and associated PKCII detected by anti-PKCII antibody (top blot). The same blot was stripped and
reprobed for different TRPV channels by anti-V5 antibody (middle blot). Thebottomblot shows the expression of PKCII in total cell lysates (TCL) fromall groups. Note that TRPV2, TRPV3, and TRPV4
have the same nonspecific background bindings to PKCII as observed in control (lane 1), whereas the binding to TRPV1 is twice as high as in the other groups. PKCII binding was normalized to
the corresponding total expression of PKCII, giving rise to the following relative amount of PKCII binding: 0.45 for control, 1.04 for TRPV1, 0.49 for TRPV2, 0.48 for TRPV3, and 0.55 for TRPV4.D,
PKCII binds to the TRPV1 N terminus. GST-coupled TRPV1 N-terminal and C-terminal fragments were purified and incubatedwith purified PKCII. Bound PKCII was detected (top blot). The blot
was stripped and reprobedwith anti-GST to show equal levels of TRPV1 fragments (bottom blot). E, PKC does not bind directly to TRPV1. Experiments were performed as inD except that HEK293
cell lysate expressing PKCwas included for the binding assay. F, TRPV1 binds to the kinase domain (KD) from PKCII. The GST-coupled C1C2 domain (1
340) and the KD domain (341
73) from
PKCII were incubated with cell lysate expressing TRPV1. Associated TRPV1 was detected with anti-V5 antibody (top blot). The blot was stripped and reprobed with anti-GST to show similar
expression of all GST fragments. G, GST-coupled kinase domain of PKCII binds to TRPV1, but not to TRPV2, TRPV3, or TRPV4 (all tagged with V5) in a similar GST pull-down assay as in F. All blots
were repeated at least three times, with similar results.
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suggesting that enhanced constitutive activity of the TRPV1
channel itself caused by PKCII is the main cause of protein
downregulation. Consistent with this idea, the expression of
TRPV1 F641L, a channel pore mutant endowing channels with
high constitutive basal activity (Myers et al., 2008; Myers et al.,
2008), was barely detected, but the expression of this mutant was
increased dramatically after blocking channels withRR (Fig. 3H).
These highly active TRPV1 channels cause steady rises in intra-
cellular calcium, leading to a cytotoxic effect (Myers et al., 2008),
which may explain the downregulation of TRPV1.
We then investigated how the binding of PKCII enhanced
the basal activity of TRPV1. This effect could be achieved through
either direct physical binding of PKCII leading to conforma-
tional changes in TRPV1 or enhanced catalytic enzyme activity of
PKCII or both. To discriminate between these possibilities, we
constructed two kinase-inactive PKCII mutants by mutating
two residues (K371 and T500) on PKCII that are essential for
catalytic activity. The downregulation of TRPV1was abolished by
both kinase-dead PKCII mutations (Fig. 4A) despite the fact
that bothmutants still bound to TRPV1 (data not shown). Further-
more, coexpression of the kinase domain of PKCII, an identified
TRPV1-binding region, was not sufficient to cause the downregula-
tionofTRPV1(Fig. 4B).These results suggest that increasedcatalytic
activity of PKCII as a result of binding, not the direct physical
binding per se, is mainly responsible for the enhanced function of
TRPV1andconsequentdownregulationof the channel, presumably
through a phosphorylation-dependent mechanism.
Phosphorylation of TRPV1 by PKC is a major mechanism
underlying the sensitization of TRPV1 and consequent inflam-
matory hyperalgesia (Cesare et al., 1999; Zhang et al., 2007). Two
PKC phosphorylation sites, S502 and S801, have been identified
as key residues for the sensitization of TRPV1 (Numazaki et al.,
2002; Bhave et al., 2003; Zhang et al., 2008). However, mutating
these two PKC phosphorylation sites did not prevent the down-
regulation of TRPV1 elicited by PKCII (Fig. 4C). Instead, the
downregulation of the S502A/S801A TRPV1 mutant was pre-
vented by RR, similar to wild-type TRPV1 (Figs. 3F, 4D). These
results suggest that there are other, as yet unidentified PKCII
phosphorylation sites on TRPV1 that are essential for enhanced
constitutive activity of TRPV1 channels.
Figure 3. Downregulation of TRPV1 and PKCII. A, Expression of TRPV1 was downregulated by PKC and PKCII, but not by PKC or PKC. HEK 293 cells were transfected with TRPV1–V5
together with different PKC isoforms (all tagged with GFP at their N terminus) as indicated. The expression of TRPV1 was detected with anti-V5 antibody (top blot). The blot was stripped and
reprobed for PKCs with anti-GFP, followed by further stripping and reprobing with antitubulin to show similar expression of tubulin and thus similar sample loading in all cases (bottom blot). B,
Downregulation of PKC andII by TRPV1. HEK 293 cellswere transfectedwith different GFP-tagged PKC isoforms as indicated togetherwith () orwithout () TRPV1. The expression of all PKCs
wasdetectedbyanti-GFP (topblot). Theblotwas strippedand reprobedwithantitubulin to showsimilar expression inall groups (bottomblot).C, Time courseof downregulationof TRPV1byPKCII.
TRPV1–V5, andPKCII-pTRE2were cotransfected in Tet-OnHEK293 cells. Twenty-four hours after transfection, PKCIIwas inducedbyDOX for different times, as indicated. Theexpressionof TRPV1
(top blot) and PKCII (middle blot) was detected by anti-V5 and anti-PKCII, respectively. The blot was stripped and reprobed with antitubulin showing similar expression in all cases. D, E,
Proteolytic enzymes (D) and organelles (E) are not involved in PKCII-induced downregulation of TRPV1. HEK-293 cells were transfected with TRPV1–V5 or together with PKCII, as indicated.
Transfected cellswerepretreatedwith Z-VAD (50M; to inhibit caspase), calpeptin (5M; to inhibit calpain), phenanthroline (Phe, 2mM; to inhibitmetallo-protease),MG132 (1M), and lactacystin
(5M; to inhibit proteasome) for 20 h before solubilization. TRPV1 was detected by anti-V5 (top blot) followed by stripping and reprobing with antitubulin (bottom blot). F, Downregulation of
TRPV1 by PKCII was prevented by TRPV1 blockers. Tet-On HEK-293 cells were cotransfected with TRPV1–V5 and PKCII-pTRE2. PKCII was induced 24 h after transfection for an additional 24 h
with () orwithout () ruthenium red RR (10M) or BCTC (10M), as indicated. The blotwas probed for TRPV1with anti-V5 (top blot), followed by stripping and reprobingwith anti-PKCII. The
blot was then further stripped and reprobed with antitubulin to show equal sample loading in all cases (bottom blot). G, Downregulation of PKCII by TRPV1 was prevented by RR. HEK 293 cells
expressing TRPV1–V5 and PKCII were treated with RR (10M) as indicated. The top blot shows the detection of PKCII. The blot was stripped and reprobed with antitubulin (bottom blot). H,
TRPV1F641Lprotein expressed fromHEK293 cellswasprobedwithanti-V5 (topblot), followedby strippingand reprobingwithantitubulin (bottomblot). All blotswere repeatedat least three times,
with similar results. Molecular weights are shown on the right for all blots.
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Several serine and threonine residues on TRPV1, apart from
S502 and S801, have been identified as PKCphosphorylation sites
in vitro andmost of these have no assigned functions (Bhave et al.,
2003). We therefore mutated all other potential PKC phosphor-
ylation sites and investigated whether the downregulation of
TRPV1 caused by enhanced activity of channels evoked by
PKCII could be prevented. We found that the downregulation
of TRPV1was reduced dramatically bymutating Thr705, but not
by mutating other potential PKC phosphorylation sites (Fig.
4E,F), suggesting that Thr705 on TRPV1 is a functionally rele-
vant PKCII phosphorylation site. To determine whether
PKCII phosphorylates Thr705 directly, we performed an in
vitro PKC phosphorylation assay using the GST-coupled TRPV1
C-terminal fragment and the T705A C-terminal fusion protein.
Figure 4G shows that PKCII did not cause threonine phosphor-
ylation of the control GST protein, but increased threonine
phosphorylation of the GST-coupled TRPV1 C terminus dra-
matically. The increased threonine phosphorylationwas substan-
tially reduced by mutating Thr705, showing that Thr705 is
indeed a major PKCII phosphorylation site.
Figure4. Downregulation of TRPV1byPKCII depends on thephosphorylation of TRPV1at Thr705.A,B, Catalytic activity of PKCII is essential for the downregulation of TRPV1. Tet-OnHEK-293
cellswere transfectedwith TRPV1–V5 togetherwith different PKCIImutants or the kinase domain (KD) fromPKCII in pTRE2 vector as indicated. Twenty-four hours after transfection, PKCII was
induced with DOX for 24 h (). Expression of TRPV1 was detected by anti-V5 (top blot). The blot was stripped and reprobed with anti-PKCII (middle blot) and antitubulin (bottom blot). C, Two
phosphorylation sites for PKC are not involved in the downregulation of TRPV1by PKCII. Tet-On HEK293 cells were transfected with wild-type (WT) TRPV1 or double mutant (DM)-TRPV1
(S502A/S801A) together with PKCII-pTRE2. PKCII induced 24 h after transfection. Expression of TRPV1and PKCII was detected by anti-V5 (top blot) and anti-PKCII (middle blot). The bottom
blot shows equal expression of tubulin and sample loading for all groups. D, Downregulation of double mutants (DM)-TRPV1 was prevented by RR. Tet-On cells expressing DM-TRPV1–V5 and
PKCII-pTRE2were treatedwithDOX in thepresence of RR (10M) as indicated. TRPV1wasdetectedwith anti-V5 (top). Theblotwas strippedand reprobedwith antitubulin, showingequal loading
(bottomblot). E, Downregulation of TRPV1by PKCII was prevented bymutating T705. Tet-OnHEK293 cellswere transfectedwith PKCII-pTRE2, alongwith different TRPV1mutants, as indicated.
PKCII expression was induced for 24 h with DOX. TRPV1 (top blot) and PKCII (middle blot) were detected by anti-V5 and anti-PKCII, respectively. Blots were stripped and reprobed with
antitubulin (bottomblot). F, Quantification of downregulation of TRPV1mutants by PKCII in at least two experiments similar to those in E. All error bars indicatemean	 SEM. NS, Not significant.
***p 0.001 comparedwithwild-type (WT) TRPV1.G,H, In vitro phosphorylation of purified GST-coupled TRPV1 C-terminal fragment and the T705Amutant (as indicated) by purified PKCII (G)
or immunoprecipitated PKCII (H ). Protein phosphorylation was detected by anti-phosphothreonine antibody (top blot). The bottom blot is a Coomassie blue stain of corresponding purified
proteins. All blots were repeated at least three times, with similar results. Molecular weights are shown on the right for all blots.
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PKCII enhances TRPV1 activity by phosphorylatingThr705.
Our evidence also suggests that the enzyme activity of PKCII is
stimulated simply by a direct physical binding of TRPV1 without
the need for additional signaling. To test this idea, PKCII was
immunoprecipitated from cell lysates containing PKCII either
alone or together with TRPV1 to perform an in vitro immuno-
precipitation kinase assay. As expected, the presence of TRPV1
increased threonine phosphorylation of the TRPV1 C terminus
significantly (Fig. 4H), demonstrating that TRPV1 binding facil-
itates the activation of PKCII. Together, these results demon-
strate that activated PKCII, as a result of direct binding of
TRPV1 to its kinase domain, downregulates TRPV1 channels
by enhancing the basal constitutive activity of TRPV1 through
phosphorylation of T705. This residue may therefore have a
previously unrecognized role in tuning the activity of TRPV1
channels.
Sensitivity of TRPV1 channels is enhanced by PKCII, but
not by PKC
We designed shRNA constructs to knock down the expression of
PKC and PKC selectively. Both constructs potently reduced
the expression of PKC and PKC, respectively, inHEK293 cells,
whereas corresponding scrambled shRNAs had no effect (Fig.
5A). To determine the effect of PKCII on the function of TRPV1
directly, we measured inward currents carried by TRPV1 as a
function of different concentrations of capsaicin. The sensitivity
of TRPV1 to capsaicin was markedly increased after the induc-
tion of PKCII for 8 h by DOX, resulting in a negative shift of the
dose–response curve (Fig. 5B). This occurred despite the fact that
a moderate downregulation of TRPV1 was induced at this time
point, showing that functional enhancement elicited by PKCII
overrides PKCII-induced TRPV1 downregulation. The in-
creased sensitivity of TRPV1 was, however, abolished by induc-
ing the catalytically inactive PKCII mutant K371R (Fig. 5B),
which also abolished the downregulation of TRPV1 (Fig. 4A).
Conversely, knocking down endogenous PKCII reduced the
sensitivity of TRPV1 dramatically, yielding a positive shift of the
curve (Fig. 5B). A similar reduction in the sensitivity of TRPV1
was also observed with the PKCII phosphorylation site-ablated
TRPV1mutant T705A (Fig. 5C). Importantly, the T705Amutant
abolished PKCII-induced enhancement of the sensitivity of
TRPV1 to capsaicin (Fig. 5C). These data show that the phos-
phorylation of TRPV1 by catalytically activated PKCII under-
lies increases in the sensitivity of TRPV1. To determine the effect
of PKCII on the gating of TRPV1 by voltage, we monitored
voltage-dependent currents mediated by TRPV1. The outward
currents activated by depolarization were increased by induction
of wild-type PKCII, but not by induction of the enzyme-
Figure 5. PKCII increases the sensitivity of TRPV1 through a phosphorylation-dependent mechanism. A, Knock down of PKCII and PKC by shRNAs. HEK-293 cells were transfected with
scrambled or PKCII shRNA (top two blots) or PKC shRNA (bottom two blots), as indicated. PKCII and PKCwere detectedwith anti-PKCII and anti-PKC, respectively. Blots were stripped and
reprobed with antitubulin to show equal loading in all groups. B, Normalized whole-cell inward currents as a function of different capsaicin concentrations in Tet-On HEK293 cells. Shown are the
control dose–response curve (), EC50 84.51 nM; PKCII induction for 8 h with DOX (Œ), EC50 38.15 nM; cotransfection with PKCII shRNA (), EC50 155.01 nM; and cotransfection with
PKCII K371Rwith DOX induction (), EC50 92.56 nM. PKCII expression was induced by DOX for 8 h. All curves fitted with the Hill equation with a Hill coefficient of 1.5. C, Increased sensitivity
of TRPV1 to capsaicin inducedby PKCII was abolished bymutating T705. Shownare thewild-type (WT) TRPV1dose–response curve (), EC50 84.51 nM; the T705A TRPV1dose–response curve
(), EC50 201.2 nM; and the T705A TRPV1 dose–response curve inducedwith DOX for PKCII expression (Œ), EC50 171.3 nM.D, TRPV1 currents evoked by a voltage ramp (from120mV to
160mV, 650ms)were increased by PKCII inductionwithDOX (blue curve), but inhibited by PKCII shRNA (red curve). DOX-induced increases in TRPV1 currentswere abolished by PKCII K371R
(pink curve). All I–V curves are averages of 16
22 recordings. E, PKC does not affect the sensitivity of TRPV1 to capsaicin. Normalized whole-cell inward currents plotted against different
concentrations of capsaicin as in B. Control curve (E), EC50 86.94 nM; cotransfection with PKC (Œ), EC50 79.46 nM; and cotransfection with PKC shRNA (), EC50 93.43 nM. The Hill
coefficient is 1.5. F, TRPV1 currents evoked by a voltage ramp (from120 mV to160 mV, 650 ms) were reduced by mutating T705 (red curve), but not by mutating two PKC phosphorylation
sites S502A/S801A (DM TRPV1; pink curve) nor by coexpression with PKC (blue curve). All I–V curves are averages of 16
29 recordings.
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activity-deficient PKC mutant K371R (Fig. 5D). As expected,
depolarization-induced currents were reduced robustly by either
knocking down PKCII (Fig. 5D) or mutating the PKCII phos-
phorylation site T705 (Fig. 5F). These data show that phosphor-
ylation of TRPV1 at T705 by PKCII is critical for the gating of
TRPV1 by both capsaicin and voltage.
PKC is another PKC isoform involved in the potentiation
of TRPV1 after activation by inflammatory mediators such as
bradykinin (Cesare et al., 1999). Surprisingly, neither overex-
pression nor downregulation of PKC had any effect on the
sensitivity of TRPV1 (Fig. 5E). Furthermore, no effect onTRPV1
outward currents activated by depolarization was observed after
overexpression of PKC, and the PKC phosphorylation-site-
ablated TRPV1 mutant (S502A/S801A) showed similar voltage-
dependent outward currents aswild-typeTRPV1 (Fig. 5F). These
findings suggest that the basal sensitivity of TRPV1 is not deter-
mined by PKC and that PKC is mainly in an inactive state
under basal condition, so it cannot regulate TRPV1 until activa-
tion by additional signaling, such as from Gq-protein-coupled
receptors.
PKCII determines the heat sensitivity of TRPV1
We next measured the heat activation of TRPV1 by exposing
cells to a temperature ramp from 22°C up to 48°C in Tet-On
HEK293 cells expressing TRPV1. TRPV1 was typically activated
at
40.5°C in these cells (Fig. 6A,B,E). The induction of PKCII
with DOX significantly reduced the activation threshold of
TRPV1 to 36.8°C (Fig. 6C,E), equivalent to the effect of a TRPV1
deletion mutant in which a proposed PIP2-binding region
(777
820) in the C terminus has been removed, thus rendering
the channel hyper-heat sensitive (Prescott and Julius, 2003; Fig.
6F). The activation threshold for heat was further significantly
reduced in the deletionmutant after PKCII induction (Fig. 6F),
suggesting a nonoverlappingmechanismused by PKCII and the
TRPV1 deletion mutant for enhancing the heat sensitivity of
TRPV1. Concomitantly, the peak heat currents were also signif-
icantly larger after PKCII induction (Fig. 6C,F). Remarkably,
TRPV1 was almost heat insensitive after knocking down endog-
enous PKCII and only a small, nonspecific membrane current
was observed (Fig. 6D,E). The lack of heat-induced responses is
not due to the absence of function of TRPV1, because a subsatu-
rating concentration of capsaicin (1 M) still induced a similar
inward current as that in the control condition (Fig. 6D). In
contrast, no effect was observed on either heat thresholds or peak
heat currents by overexpression of PKC or by knocking down
endogenous PKC (Fig. 6F). The N-terminal proximal domain
of TRPV1 has been implicated as a thermal sensor of TRPV1
channels (Yao et al., 2011). Therefore, it was interesting to deter-
Figure 6. Heat sensitivity of TRPV1 is increased by PKCII. A, Representative inward currents carried by TRPV1 (top left trace) induced by a temperature ramp shown underneath in a Tet-On
HEK-293 cell expressing TRPV1 and PKCII-pTRE2. Right, Inward currents evoked by capsaicin (1M, 5 s) applied at the end of temperature ramp.B, Arrhenius plot of inward current shown inA as
a function of absolute temperature. The threshold heat temperaturewas estimated to be 40.1°C from the intersection of two different slopes (red lines). C,D, Example of TRPV1 inward current (top
trace on the left) evoked by a temperature ramp shown underneath in a Tet-On HEK 293 cell when PKCII was induced by DOX for 8 h (C) or coexpressing PKCII shRNA (D). Capsaicin (1M, 5 s)
applied after a temperature ramp (right). E, Current-temperature relationship from recorded cells in A, C, and D. F, Summary of heat threshold for TRPV1 and peak amplitudes of heat-induced
currents in experiments similar to those in A–D. The number of experiments is given under each bar. All error bars indicate mean	 SEM. NS, Not significant. *p 0.05; ***p 0.001. Note that
the heat threshold cannot bemeasured in cells treatedwith PKCII shRNA due to small heat currents. The heat thresholdwas reduced by PKCII to a similar level as in a hyper-heat-sensitive TRPV1
deletionmutant (CD777 TRPV1). G, Summary of heat thresholds and heat-induced peak currents in Tet-On HEK-293 cells expressing TRPV1 and PKCII mutants (K371R, T500V)-pTRE2 (bars 1–4)
or in cells expressing PKCII-pTRE2 and doublemutant (DM, S502A/S801A) TRPV1 (bars 5 and 6). The number of experiments is given above each bar. All error bars indicatemean	 SEM. NS, Not
significant. *p 0.05; **p 0.01; ***p 0.001.
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mine whether PKCII may have caused changes in the thermal
sensitivity of TRPV1 through a direct physical binding to the
thermal sensor. Figure 6G shows that the heat activation thresh-
old for TRPV1 was not significantly reduced after inducing the
catalytically inactive PKCII mutants (K371R and T500V), al-
though there were small but significant increases in the peak heat
currents. The small enhancement in peak heat currents may be
caused by the direct physical binding of PKCII to TRPV1. Collec-
tively, thesedata suggest that thecatalytic enzymeactivityofPKCII,
but not PKC, is the main cause of enhanced heat responses of
TRPV1, presumably through a phosphorylation-dependent mech-
anism, and that the direct physical binding of PKCII has only a
minor role in regulating the heat sensitivity of TRPV1.
We have identified T705 on TRPV1 as a key PKCII phos-
phorylation site. We next determined the heat sensitivity of the
T705A TRPV1mutant. Figure 7A shows that a similar heat ramp
induced amuch smaller current in T705ATRPV1 comparedwith
wild-type TRPV1, with a significantly higher activation thresh-
old. However, the peak current elicited by a submaximal concen-
tration of capsaicin (1 M) in the T705A mutant was similar to
that in wild-type TRPV1 (Fig. 7A). The T705Amutant also abol-
ished PKCII-induced enhancement of the activation of TRPV1
by heat (Fig. 7B). In contrast, the PKC phosphorylation-site-
ablated mutant did not abolish the reduction in the heat thresh-
old of TRPV1 induced by PKCII (Fig. 6G), suggesting that T705
is a key residue in regulating the heat sensitivity of TRPV1.
We then examined the mechanisms causing T705A TRPV1 to
be less responsive to heat. The activation of TRPV1 by heat was
suggested to be caused by the shift in the transmembrane voltage
toward a physiological membrane potential (Voets et al., 2004).
As reported before (Voets et al., 2004; Zhang et al., 2008), wild-
type TRPV1 showed strong voltage dependence after steps of
depolarization, but similar voltage steps induced much smaller
outward currents with T705A TRPV1 (Fig. 7C), causing a posi-
tive shift in voltage-dependent activation curve and a much
higher V1/2 (Fig. 7D,E).
Together, these results suggest that the heat sensitivity of TRPV1
is critically dependent on PKCII, which acts by phosphorylating
T705. This residue thus has a pivotal role in determining the sensi-
tivity of TRPV1 elicited by thermal and chemical stimuli.
PKCII is not involved in the potentiation of TRPV1 evoked
by the activation of a Gq-protein-coupled receptor
Because the basal sensitivity of TRPV1 is determined by PKCII,
we investigated whether PKCII was also involved in the sensiti-
zation of TRPV1 induced by bradykinin (BK). BKbinds to the BK
B2 receptor (B2R), leading to the translocation and activation of
PKC, which then phosphorylates TRPV1 at two main residues,
S502 and S801, leading to the sensitization of TRPV1 (Zhang et
al., 2008). As shown previously (Zhang et al., 2008), BK induced
a potent sensitization of TRPV1 in HEK293 cells expressing
TRPV1 and B2R (Fig. 8A). The sensitization of TRPV1 evoked by
BK was completely abolished by knocking down PKC (Fig.
8B,D), confirming the critical role of PKC in this process. How-
ever, downregulating PKCII had no effect on the BK-induced
sensitization of TRPV1 currents elicited by capsaicin (Fig. 8C,D).
Moreover, the BK-induced sensitization of TRPV1was not atten-
uated in the PKCII phosphorylation-site-ablated TRPV1 mu-
tant T705A (Fig. 8E,F), which, however, did abolish enhanced
sensitivities of TRPV1 caused byPKCII. These data indicate that
PKC, but not PKCII, is critical for the potentiation of TRPV1
caused by the activation of Gq protein-coupled receptor, but
Figure 7. Heat sensitivity of TRPV1 is determined by the phosphorylation of T705 induced by PKCII. A, Example of inward current (top left trace) induced by a temperature ramp shown under
Tet-OnHEK-293 cells expressing T705ATRPV1. Right, current elicited by capsaicin (1M, 5 s) applied at the endof temperature ramp.B, Summary of heat thresholds andheat-inducedpeak currents
in experiments similar to those in A. The number of experiments is given above each bar. All error bars indicate mean	 SEM. NS, Not significant. ***p 0.001. C, Representative TRPV1 currents
elicitedby voltage steps from140mV to200mV in20mV increments inHEK293 cells expressingwild-type (WT) or T705ATRPV1, as indicated.D, Normalized conductance-voltage relationship
for cells in C fitted by aBoltzmann functionwith values ofV1/2 and steepness factors as follows:WT TRPV (), 139.5mV, 33.98mV; T705A TRPV1 (ƒ), 198.9mV, 33.05mV.E, Summary ofV1/2 values
from experiments similar to those in C. The number of experiments is given above each bar. All error bars indicate mean	 SEM. ***p 0.001.
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PKC is not involved in regulating the basal sensitivity of the
channel.
PKCII is required for the responsiveness of TRPV1 in
DRG neurons
We next analyzed heat responses in cultured rat DRG neurons. A
temperature ramp up to 48°Cwas used to activate low-threshold,
heat-sensitive neurons, most of which are capsaicin sensitive and
thus are mainly mediated by TRPV1. Conversely, another popu-
lation of high-threshold heat-sensitive neurons (50°C) are nor-
mally capsaicin insensitive and will not be activated by the
temperature ramp used (Nagy and Rang, 1999a; Caterina et al.,
2000). Of 38 recorded neurons, 13 neurons (34.2%) were heat
sensitive and also activated by capsaicin, thus expressing TRPV1.
These TRPV1neurons had a typical heat activation threshold of
42.4°C (Fig. 9A). The proportion of heat-sensitive neurons was sig-
nificantly increased after expression of
PKCII in the DRG neurons (0.01 p
0001, 2 test). In this case, 28 of 42 re-
corded neurons (66.7%) were heat sensi-
tive and 27 of these heat-sensitive neurons
were responsive to capsaicin,with a signif-
icantly lower thermal threshold of 39.7°C
and much bigger peak heat currents (Fig.
9A,B). We then expressed PKC shRNA
in the neurons, resulting in pronounced
reductions in the expression of PKCII
(Fig. 9C). Interestingly, a significantly
lower percentage of neurons (12.8%, 5 of
39, p  0.05, 2 test) were responsive to
heat in neurons transfected with PKC
shRNA. All five of these neurons were also
capsaicin sensitive and had a significantly
higher heat threshold (44.9°C) and much
smaller peak heat currents (Fig. 9A,B).
We further compared the peak current
amplitudes elicited by capsaicin (1 M).
Transfection of neuronswith PKCII, but
not PKC, increased capsaicin-evoked
currents robustly (Fig. 9D,E). Con-
versely, knocking down PKCII reduced
dramatically TRPV1 currents activated by
capsaicin (Fig. 9D,E). It should be noted
that native TRPV1 in DRG neurons dis-
plays amuch lower sensitivity to capsaicin
than that in transfected HEK293 cells
(Kim et al., 2006). Therefore, 1 M (i.e.,
submaximal) capsaicin can produce sig-
nificant differences in TRPV1 peak cur-
rents in DRG neurons (Fig. 9D,E), but
not in transfected HEK 293 cells (Fig.
6A,C,D). These results demonstrate that
the heat sensitivity and responsiveness of
TRPV1 depends critically on the coex-
pression of PKCII in DRG neurons.
Discussion
The sensitivity of peripheral nociceptors is
fundamental to the ability to elicit pain.
The expression of TRPV1 channels is a
molecular signature marking nociceptive
neurons. TRPV1 itself can be targeted di-
rectly and excited by a variety of chemical
and thermal stimuli producing pain and
itch. Therefore, understanding the mechanisms for determining
the sensitivity of TRPV1 is critical for understanding these
TRPV1-channel-mediated conditions. In the present study, we
report that the sensitivity of TRPV1 channels is determined by
PKCII. TRPV1 binds directly to PKCII and subsequently ac-
tivates PKCII. Activated PKCII then enhances the responsive-
ness of TRPV1 to thermal and chemical stimuli through a
phosphorylation-dependent mechanism. Remarkably, TRPV1 is
barely heat sensitive in the absence of PKCII or after ablation of
a PKCII phosphorylation site on the channel. Furthermore, ex-
pression of PKCII increased the proportion of heat-sensitive
neurons and capsaicin-induced responses and knocking down
PKCII reduced the percentage of neurons responding to heat
and capsaicin. PKCII is thus an essential accessory protein for
the gating of TRPV1, not only by chemical agonists, but also,
Figure 8. PKC, but not PKCII, is involved in the potentiation of TRPV1. A–C, Examples of whole-cell inward currents acti-
vated by capsaicin (50 nM, 5 s) from a HEK 293 cell expressing TRPV1 and the bradykinin B2 receptor (A; control) or together with
PKC shRNA (B) or PKCII shRNA (C), as indicated. The dashed line is zero current. D, Collected results of experiments similar to
those in A–C. The number of experiments is given above each bar. All error bars indicate mean 	 SEM. ***p  0.001. E,
BK-induced sensitization of TRPV1 in PKCII phosphorylation-site-ablated TRPV1 T705Amutant. Capsaicin (50 nM, 5 s) and BK (1
M) were applied as indicated. The dashed line is zero current. F, Summary of experiments similar to those in E. The number of
experiments is given above each bar. All error bars indicate mean	 SEM. ***p 0.001.
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importantly, by heat. This mechanism may underlie the varied
thermal sensitivities of TRPV1 channels expressed in different
populations of DRG neurons and in different systems in which
there are different levels of PKCII expression.
We have identified previously a TRPV1 signaling complex
formed between TRPV1 and the scaffolding protein AKAP79/
150, which then anchors PKA, PP2B, and PKC (Zhang et al.,
2008). This signaling complex is normally inactive and becomes
active only when anchored PKC becomes activated, for example,
as a result of stimulation of G-protein-coupled receptors during
inflammation and tissue injury. Therefore, the AKAP79/150-
TRPV1 complex is mainly involved in the enhancement of heat
pain (heat hyperalgesia). In the present study, TRPV1 was found
to bind directly to PKCII, but not to PKC, forming a different
local complex in a subpopulation ofDRGneurons. This complex,
however, was constitutively active and thus was mainly involved
in regulating the basal sensitivity of TRPV1 (Fig. 9F). Increased
sensitivity of TRPV1, determined by PKCII, will thereforemake
nociceptive neurons more sensitive to pain and itch-producing
chemicals and toxins.
PKC is a primary PKC isoform in the TRPV1-AKAP79 com-
plex involved in heat hyperalgesia. It acts by phosphorylating two
functional sites, S502 and S801, on TRPV1. PKCII enhances the
sensitivity of TRPV1 by phosphorylating a distinct residue
(T705) on TRPV1 (Fig. 9F). The sensitization of TRPV1 induced
by BK was abolished by either knocking down PKC or by mu-
tating two PKC phosphorylation sites; however, neither of these
manipulations had any effect on the sensitivity of TRPV1 (i.e., no
changes in the activation by capsaicin, voltage, and temperature).
Conversely, the sensitivity of TRPV1was reduced substantially by
either downregulating PKCII or ablating the PKCII phos-
phorylation site, neither of which had any effect on the sensitiza-
tion of TRPV1 induced by BK (Fig. 9F). These studies
demonstrate clearly that the sensitivity of TRPV1, determined by
the phosphorylation of T705, and the potentiation of TRPV1,
determined by the phosphorylation of S502 and S801, are two
separate processes involving different mechanisms. It is likely
that the thermal threshold of TRPV1 will be reduced to an even
lower level by activated PKC after inflammation in a subset of
PKCII-expressing neurons inwhich the basal thermal threshold
is already very low. Therefore, two different PKC isoforms act in
concert to regulate different aspects of pain mediated by TRPV1.
In addition to enhancing the sensitivity of TRPV1, constitu-
tively activated PKCII, as a result of physical binding of TRPV1,
may also target other ion channels and/or signaling messengers
such as voltage-gated sodium and potassium channels, the activ-
ities of which are also regulated by PKC-mediated phosphoryla-
tion (Li et al., 1993; Enyedi and Czirjak, 2010). The regulation of
these ion channels by PKCmay further facilitate the transduction
of pain and/or itch. Therefore, a subpopulation of DRG neurons
expressing TRPV1-PKCII complexes may represent a popula-
tion of hypersensitive nociceptive neurons that have a more
prominent role in thermal hyperalgesia and pain.
In many cases, ion channels are expressed as part of a specific
protein complex containing auxiliary proteins, which strongly
influence the activation, inactivation, and modulation of the
channels (Isom et al., 1994). These ion channel complexes diver-
sify the function of ion channels, allowing ion channels to per-
Figure 9. PKCII is required for the responsiveness of DRG neurons to heat and capsaicin. A, Representative inward currents from a DRG neuron under control conditions (left), from a neuron
transfected with GFP-PKCII (middle), and from a neuron transfected with PKCII shRNA (right) activated by a temperature ramp shown underneath for each condition. B, Summary of heat
thresholds and peak heat currents in experiments similar to those in A. Only capsaicin-sensitive neurons, which express TRPV1, were included in the analysis. The number of neurons is given above
each bar. All error bars indicatemean	 SEM. **p 0.01; ***p 0.001. C, DRG neuronswere transfectedwith GFP-PKCII shRNA. Neuronswere then immunostainedwith anti-PKCII. Left, GFP
fluorescence indicating successfully transfectedneurons. Right, expressionof PKCII. The expressionof PKCIIwas absent fromall GFPneurons (n45). Scale bars, 10m.D, Exampleof inward
currents activated by capsaicin (1M, 5 s) from a DRG neuron under control condition (in black), transfectedwith GFP-PKCII (in red), and transfectedwith PKCII shRNA (in blue). The dashed line
is zero current. E, Summary of results in experiments similar to those inD. The last bar is fromneurons transfectedwith GFP-PKC. The number of experiments is given below each bar. All error bars
indicatemean	 SEM. ***p0.001.F, Schematic summaryof regulationof TRPV1byPKCII andPKC. PKCII binds directly to theN terminus of TRPV1, leading to the activationof PKCII,which
then phosphorylates T705 (shownby a star) in the C terminus of TRPV1. Phosphorylation at this residue enhances the excitability of TRPV1 channels. In contrast, PKC interactswith TRPV1 indirectly
through the scaffolding protein AKAP79,which binds to TRPV1 C terminus (Zhang et al., 2008). PKC is in an inactive statewithin this complex and can only be activated by additional signaling such
as via activation of the Gq-coupled receptor B2R. Activated PKC phosphorylates two residues at S502/S801, leading to the potentiation of TRPV1.
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form appropriate functions in different cells and systems. In the
present study, we discovered that the function of TRPV1 chan-
nels was contingent on coexpression of PKCII, which binds
constitutively to the channel. Therefore, PKCII acts as an aux-
iliary subunit of TRPV1, controlling its sensitivity. The N termi-
nus of TRPV1 contains several important structural domains,
including the ankyrin repeat domain and the membrane proxi-
mal domain. In particular, the membrane proximal domain in
theN terminus has been implicated as a thermal sensor of TRPV1
(Yao et al., 2011). It is thus tempting to assume that PKCII
mightmodulate TRPV1 through a physical interactionwith these
structural domains. However, the bound PKCII modulates
TRPV1 functionmainly through induced catalytic enzyme activ-
ity as a result of binding; direct physical binding per se plays only
aminor role, in contrast tomany other ion channel complexes in
which auxiliary subunits influence the function of channels
through direct physical binding. This model of modulation is
very special, because PKCII and TRPV1 are mutually activated
simply through a process of physical binding.
This study also raises the question of how the phosphorylation
of TRPV1 by PKCII affects the gating process of the channel. It
is generally believed that temperature, voltage, and capsaicin
open TRPV1 by acting on distinct structural modules (sensors),
which then couple allosterically to a gating pathway on the chan-
nel (Latorre et al., 2007). In support of this idea, a tyrosine residue
in the second transmembrane domain is specifically required for
capsaicin gating, but does not affect either voltage or temperature
gating (Jordt and Julius, 2002). The outer pore region of TRPV1
was suggested to act as a thermal sensor becausemutations in this
region specifically impair heat activation without grossly affect-
ing either capsaicin- or voltage-induced activation of TRPV1
(Grandl et al., 2010; Yang et al., 2010). However, several other
modular domains have also been implicated as thermal sensors,
including theN-terminal proximal domain (Yao et al., 2011) and
the C-terminal domain (Brauchi et al., 2007). It is unclear
whether these domains serve as thermal sensors or function as
allosteric couplers between temperature sensing and gate open-
ing. In the present study, we observed that the phosphorylation of
TRPV1 at T705 by PKCII was critical for the activation of
TRPV1 by heat, as well as by capsaicin and voltage. T705 is lo-
cated in the TRP domain in the C terminus of TRPV1. The re-
cently resolved structure of TRPV1 revealed significant contacts
between the TRP domain and the pre-S1 helix, a region analo-
gous to the N-terminal proximal domain, suggesting that these
contacts are important for allosteric coupling between channel
domains (Liao et al., 2013). It is likely that phosphorylation of
TRPV1 by PKCII at T705 in the TRP domain may influence
these contacts, resulting in enhanced gating. Collectively, then,
the Thr705 residue has a key role in the gating of TRPV1.
Our study demonstrates that the sensitivity of TRPV1, in par-
ticular to temperature, requires the presence of PKCII and
phosphorylation at T705. The phosphorylation byPKCII is thus
a required precondition for driving TRPV1 channels into an op-
timal state for activation, even though TRPV1 channels are in-
trinsically heat sensitive. We emphasize, then, that the
thermosensor is not always a single molecule, but rather acts as a
molecular complex. Consistent with this idea, our previous study
also identified a cold complex consisting of the cold-sensitive
TRPM8 channel and the Gq protein, allowing efficient and
rapid inactivation of TRPM8 channels during inflammation
(Zhang et al., 2012; Li and Zhang, 2013).
Sensory neurons are highly heterogeneous in nature, enabling
them to respond appropriately to a diversity of environmental
and endogenous stimuli with different qualities and intensities.
Ion channel–protein complexes have emerged as an elegant
mechanism allowing for ion channels in different population of
neurons to react differentially to even subtle changes in intensity.
A subset of hyper-constitutively sensitive sensory DRG neurons
expressing TRPV1-PKCII complexes may be attractive targets
for developing novel therapies against pain and itch.
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